Upregulation of Transforming Growth Factor‐β1 and Vascular Endothelial Growth Factor Gene and Protein Expression in Cyclosporin‐Induced Overgrown Edentulous Gingiva in Rats

BACKGROUND To examine the effects of cyclosporin A (CsA) on the expression of growth factors in induced gingival overgrowth with limited contributing factors arising from local inflammation caused by bacterial plaque, this study of gingival overgrowth was designed on the edentulous ridge of rats. METHODS After a 3-week healing period following maxillary molar extractions, 16 five-week-old male Sprague-Dawley rats were assigned to CsA and control groups. Animals in the CsA group were fed 30 mg/kg CsA daily, whereas the control rats received a mineral oil vehicle instead. After 4 weeks, all animals were sacrificed, and the morphology of edentulous ridges was recorded by dental impression. The gingivae on the left-hand side were dissected and stored for mRNA analysis, whereas the gingivae on the right-hand side were fixed in 4% paraformaldehyde for immunohistochemistry (IHC) analysis of transforming growth factor-beta1 (TGF-beta1), platelet-derived growth factor beta (PDGF-beta), insulin-like growth factor-1 (IGF-1), and vascular endothelial growth factor (VEGF). RESULTS The edentulous gingivae were enlarged and the body weights were reduced in the CsA-treated animals compared to controls. The mRNA expressions of TGF-beta1, IGF-1, and VEGF were higher in the gingivae of the CsA group than in the control group. In addition, a greater mRNA expression (7.21-fold) of VEGF was demonstrated in the CsA group than in the control group by real-time polymerase chain reaction (PCR). The percentages of cells staining positive for TGF-beta1 and VEGF were significantly greater in the CsA rats than in the control rats. CONCLUSIONS Greater mRNA expression and positive staining for TGF-beta1 and VEGF were observed in the edentulous gingivae of rats that received CsA. Therefore, CsA may upregulate TGF-beta1 and VEGF gene expression and protein secretion in CsA-induced gingival overgrowth.

[1]  A. Flyvbjerg,et al.  The role of vascular endothelial growth factor (VEGF) in renal pathophysiology. , 2004, Kidney international.

[2]  I. Chapple,et al.  Crevicular fluid levels of TGFbeta1 in drug-induced gingival overgrowth. , 2004, Archives of oral biology.

[3]  O. Kim,et al.  Decreased expressions of thrombospondin 2 in cyclosporin A-induced gingival overgrowth. , 2004, Journal of periodontal research.

[4]  B. Levy,et al.  A Molecular Defect in Intracellular Lipid Signaling in Human Neutrophils in Localized Aggressive Periodontal Tissue Damage1 , 2004, The Journal of Immunology.

[5]  R. Rosenfeld.  Insulin-like growth factors and the basis of growth. , 2003, The New England journal of medicine.

[6]  S. Takashiba,et al.  C-jun N-terminal kinase (JNK) inhibitor, SP600125, blocks interleukin (IL)-6-induced vascular endothelial growth factor (VEGF) production: cyclosporine A partially mimics this inhibitory effect. , 2003, Transplantation.

[7]  R. Coletta,et al.  Cyclosporin A induces proliferation in human gingival fibroblasts via induction of transforming growth factor-beta1. , 2003, Journal of periodontology.

[8]  O. Feron,et al.  Changes in Hsp90 expression determine the effects of cyclosporine A on the NO pathway in rat myocardium , 2003, FEBS letters.

[9]  R. Coletta,et al.  Effect of transforming growth factor-beta1, interleukin-6, and interferon-gamma on the expression of type I collagen, heat shock protein 47, matrix metalloproteinase (MMP)-1 and MMP-2 by fibroblasts from normal gingiva and hereditary gingival fibromatosis. , 2003, Journal of periodontology.

[10]  L. Rodella,et al.  Cyclosporine A up-regulates expression of matrix metalloproteinase 2 and vascular endothelial growth factor in rat heart. , 2003, International immunopharmacology.

[11]  W. Bennett,et al.  Nitric oxide modulates vascular endothelial growth factor and receptors in chronic cyclosporine nephrotoxicity. , 2003, Kidney international.

[12]  A. Ortiz,et al.  Role of Endogenous Vascular Endothelial Growth Factor in Tubular Cell Protection Against Acute Cyclosporine Toxicity1 , 2002, Transplantation.

[13]  R. Coletta,et al.  Expression of Matrix Metalloproteinases in Cyclosporin-Treated Gingival Fibroblasts Is Regulated by Transforming Growth Factor (TGF)-β1 Autocrine Stimulation , 2002 .

[14]  M. Kulka,et al.  Mast cells express chloride channels of the ClC family , 2002, Inflammation Research.

[15]  C. Caramelo,et al.  Role of Vascular Endothelial Growth Factor , 2002 .

[16]  T. Modéer,et al.  Signal pathways involved in the production of MMP-1 and MMP-3 in human gingival fibroblasts. , 2002, European journal of oral sciences.

[17]  Hong Yi,et al.  Angiotensin II regulation of vascular endothelial growth factor and receptors Flt-1 and KDR/Flk-1 in cyclosporine nephrotoxicity. , 2002, Kidney international.

[18]  Shin-Seok Lee,et al.  Cyclosporine inhibition of vascular endothelial growth factor production in rheumatoid synovial fibroblasts. , 2002, Arthritis and rheumatism.

[19]  H. Abboud,et al.  Insulin-like Growth Factor-I Induces Renal Cell Hypertrophy via a Calcineurin-dependent Mechanism* , 2001, The Journal of Biological Chemistry.

[20]  E. Vara,et al.  Cyclosporin a treatment is able to revert the decrease in circulating GH and IGF-I and the increase in IGFBPs induced by adjuvant arthritis. , 2001, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.

[21]  A. Yamaguchi,et al.  Immunohistochemical localization of members of the transforming growth factor (TGF)-beta superfamily in normal human salivary glands and pleomorphic adenomas. , 2001, Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology.

[22]  S. Nieh,et al.  Cyclosporin-induced gingival overgrowth at the newly formed edentulous ridge in rats: a morphological and histometric evaluation. , 2001, Journal of periodontology.

[23]  I. Chapple,et al.  TGF-beta isoforms and TGF-beta receptors in drug-induced and hereditary gingival overgrowth. , 2001, Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology.

[24]  N. Buduneli,et al.  Evaluation of Transforming Growth Factor-β1 Level in Crevicular Fluid of Cyclosporin A-Treated Patients , 2001 .

[25]  Y. G. Kim,et al.  Post-cyclosporine-mediated hypertension and nephropathy: amelioration by vascular endothelial growth factor. , 2001, American journal of physiology. Renal physiology.

[26]  J. Redondo,et al.  Selective Inhibition of Vascular Endothelial Growth Factor–Mediated Angiogenesis by Cyclosporin a , 2001, The Journal of experimental medicine.

[27]  A. Tanswell,et al.  Changes in Expression of Platelet-Derived Growth Factor and Its Receptors in the Lungs of Newborn Rats Exposed to Air or 60% O2 , 2000, Pediatric Research.

[28]  S. Sato,et al.  Immunoexpression of transforming growth factor β in desmoplastic ameloblastoma , 2000, Virchows Archiv.

[29]  R. Coletta,et al.  Alteration in expression of MMP-1 and MMP-2 but not TIMP-1 and TIMP-2 in hereditary gingival fibromatosis is mediated by TGF-beta 1 autocrine stimulation. , 1999, Journal of periodontal research.

[30]  A. Iacopino,et al.  Cyclosporine A-induced gingival overgrowth: a comprehensive review. , 1999, Quintessence international.

[31]  S. Tsujitani,et al.  The expression of transforming growth factor‐β1 is significantly correlated with the expression of vascular endothelial growth factor and poor prognosis of patients with advanced gastric carcinoma , 1999, Cancer.

[32]  X. Holy,et al.  Skeletal unloading induces biphasic changes in insulin-like growth factor-I mRNA levels and osteoblast activity. , 1999, Experimental cell research.

[33]  R. Todd,et al.  Eosinophil-derived transforming growth factors (TGF-α and TGF-β1) in human periradicular lesions , 1999 .

[34]  T. Halstensen,et al.  Extensive expression of TGF-beta1 in chronically-inflamed periodontal tissue. , 1999, Journal of clinical periodontology.

[35]  C. Pollock,et al.  Cyclosporin exerts a direct fibrogenic effect on human tubulointerstitial cells: roles of insulin-like growth factor I, transforming growth factor beta1, and platelet-derived growth factor. , 1999, The Journal of pharmacology and experimental therapeutics.

[36]  A. López-Calderón,et al.  The effect of cyclosporine administration on growth hormone release and serum concentrations of insulin-like growth factor-I in male rats. , 1999, Life sciences.

[37]  J. Petri,et al.  Cyclosporine A delays wound healing and apoptosis and suppresses activin beta-A expression in rats. , 1998, European journal of dermatology : EJD.

[38]  S. Murakami,et al.  Cytokine expression in periodontal health and disease. , 1998, Critical reviews in oral biology and medicine : an official publication of the American Association of Oral Biologists.

[39]  J. E. Sampaio,et al.  The influence of chlorhexidine on the severity of cyclosporin A-induced gingival overgrowth. , 1997, Journal of periodontology.

[40]  V. Everts,et al.  Cytokines modulate routes of collagen breakdown. Review with special emphasis on mechanisms of collagen degradation in the periodontium and the burst hypothesis of periodontal disease progression. , 1997, Journal of clinical periodontology.

[41]  S. Wahl,et al.  Changes in TGF-beta 1 levels in gingiva, crevicular fluid and serum associated with periodontal inflammation in humans and dogs. , 1997, European journal of oral sciences.

[42]  C. Cutler,et al.  Phenytoin and cyclosporine A specifically regulate macrophage phenotype and expression of platelet-derived growth factor and interleukin-1 in vitro and in vivo: possible molecular mechanism of drug-induced gingival hyperplasia. , 1997, Journal of periodontology.

[43]  S. Nieh,et al.  The effect of plaque retention on cyclosporine-induced gingival overgrowth in rats. , 1997, Journal of periodontology.

[44]  D. Lappin,et al.  In situ localization of cell synthesis and proliferation in periodontitis gingiva and tonsillar tissue. , 2008, Oral diseases.

[45]  C. Cutler,et al.  Cyclosporine A upregulates platelet-derived growth factor B chain in hyperplastic human gingiva. , 1996, Journal of periodontology.

[46]  J. Plemons,et al.  PDGF-B producing cells and PDGF-B gene expression in normal gingival and cyclosporine A-induced gingival overgrowth. , 1996, Journal of periodontology.

[47]  E. Bartoli,et al.  Cyclosporin A increases somatomedin C insulin-like growth factor I levels in chronic rheumatic diseases. , 1995, The Journal of rheumatology.

[48]  M. Suthanthiran,et al.  Regulation of Transforming Growth Factor-β1 (TGF-β1) Expression with a Novel TGF-β1 Complementary DNA , 1994 .

[49]  R. B. Johnson,et al.  Comparative metabolism of 3H-glucosamine by fibroblast populations exposed to cyclosporine. , 1994, Journal of periodontology.

[50]  H. Birkedal‐Hansen.  Role of cytokines and inflammatory mediators in tissue destruction. , 1993, Journal of periodontal research.

[51]  E. K. Miller,et al.  Phenytoin increases gene expression for platelet-derived growth factor B chain in macrophages and monocytes. , 1993, Journal of periodontology.

[52]  P. Nieminen,et al.  Gingival overgrowth among renal transplant recipients related to immunosuppressive medication and possible local background factors. , 1992, Journal of periodontology.

[53]  L. del Senno,et al.  Cyclosporin-A increases type I procollagen production and mRNA level in human gingival fibroblasts in vitro. , 1992, Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology.

[54]  M. Suthanthiran,et al.  Differential regulation of transforming growth factor beta and interleukin 2 genes in human T cells: demonstration by usage of novel competitor DNA constructs in the quantitative polymerase chain reaction , 1991, The Journal of experimental medicine.

[55]  G. Stricklin,et al.  Fibroblast heterogeneity in collagenolytic response to cyclosporine , 1991, Journal of cellular biochemistry.

[56]  R. Seymour,et al.  The effect of a plaque control programme on the incidence and severity of cyclosporin-induced gingival changes. , 1991, Journal of Clinical Periodontology.

[57]  M. Pabst,et al.  Interleukin‐1β‐ and tumor necrosis factor‐α‐independent monocyte stimulation of fibroblast collagenase activity , 1990 .

[58]  P. Bartold.  Regulation of human gingival fibroblast growth and synthetic activity by cyclosporine-A in vitro. , 1989, Journal of periodontal research.

[59]  N. Polli,et al.  Light and electron microscopic study of cyclosporin A-induced gingival hyperplasia. , 1986, Journal of periodontology.

[60]  P. Rotwein,et al.  Two insulin-like growth factor I messenger RNAs are expressed in human liver. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[61]  A. Hefti,et al.  Initial observation that cyclosporin-A induces gingival enlargement in man. , 1983, Journal of clinical periodontology.

[62]  A. Laupacis,et al.  Fibrous hyperplasia of the gingiva: a side effect of cyclosporin A therapy. , 1983, Oral surgery, oral medicine, and oral pathology.